NEOLA MEDICAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.91 SEK | +0.53% |
|
-4.50% | -2.05% |
| Sales 2022 | 9.74M 900K 1.23M | Sales 2023 | 9.82M 907K 1.24M | Capitalization | 109M 10.03M 13.71M |
|---|---|---|---|---|---|
| Net income 2022 | -10M -923K -1.26M | Net income 2023 | -9M -831K -1.14M | EV / Sales 2022 | -1.2 x |
| Net cash position 2022 | 40.09M 3.7M 5.06M | Net cash position 2023 | 21.58M 1.99M 2.72M | EV / Sales 2023 | 8.86 x |
| P/E ratio 2022 |
-3.4
x | P/E ratio 2023 |
-12.1
x | Employees | 7 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.19% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.53% | ||
| 1 week | -4.50% | ||
| Current month | -0.52% | ||
| 1 month | -2.05% | ||
| 3 months | +2.41% | ||
| 6 months | +42.54% | ||
| Current year | -2.05% |
1 week
1.85
2.28
1 month
1.842.80
Current year
1.482.80
1 year
1.162.80
3 years
0.904.53
5 years
0.908.00
10 years
0.908.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hanna Sjöström
CEO | Chief Executive Officer | 45 | 18-12-31 |
| Director of Finance/CFO | - | 21-12-31 | |
Sara Bergsten
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 21-12-31 | |
| Director/Board Member | 63 | 21-12-31 | |
Urban Ottosson
BRD | Director/Board Member | 63 | 19-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 1.91 | +0.53% | 33 707 |
| 24-05-02 | 1.9 | -8.65% | 68,349 |
| 24-04-30 | 2.08 | 0.00% | 26,579 |
| 24-04-29 | 2.08 | +8.33% | 102,973 |
| 24-04-26 | 1.92 | +1.59% | 30,274 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 06:55 am
More quotes
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on the patented GASMAS (Gas in Scattering Media Absorption Spectroscopy) technology. Neola Medical's technology equipment aims for continuous monitoring of the lungs of premature babies. The primary purpose of Neola Medical is to support neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts about life-threatening complications using new technology that measures lung volume changes and oxygen concentration.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.05% | 12.22M | |
| +73.17% | 12.38B | |
| -18.08% | 7.99B | |
| +16.24% | 7.21B | |
| +3.79% | 5.79B | |
| +11.77% | 5.35B | |
| +29.65% | 4.63B | |
| -17.74% | 4.17B | |
| -35.34% | 2.44B | |
| +3.59% | 2.03B |
- Stock Market
- Equities
- GPXMED Stock
